Publications
Review Article
Peptide Based Tumor Vaccines
Cancer Vaccines
1999
Authors:
Disis ML, McNeel DG, Schiffman KA, Rinn K, and Knutson KL
Journal:
Endocrine & Metabolic Investigational Drugs
Volume:
1(3)
Page:
253-9
Original Article
Immunization with recombinant human granulocyte-macrophage colony-stimulating factor as a vaccine adjuvant elicits both a cellular and humoral response to recombinant human granulocyte-macrophage colony-stimulating factor
Clinical Trials
1999
Authors:
McNeel DG, Schiffman K, Disis ML
Journal:
Blood
Volume:
93(8)
Page:
2653-9
Original Article
Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine
Cancer Vaccines
1999
Authors:
Disis ML, Grabstein KH, Sleath PR and Cheever MA
Journal:
Clinical Cancer Research
Volume:
5(6)
Page:
1289-97
Original Article
Antigen-specific recall urticaria to a peptide-based vaccine
Cancer Vaccines
1999
Authors:
Rinn K, Schiffman K, Otero HO and Disis ML
Journal:
Journal of Allergy and Clinical Immunology
Volume:
104(1)
Page:
240-2
Original Article
Antibody immunity to the HER-2/neu oncogenic protein in patients with colorectal cancer
Cancer Vaccines
1999
Authors:
Ward RL, Hawkins NJ, Coomber D, Disis ML
Journal:
Human Immunology
Volume:
60(6)
Page:
510-5
Original Article
Human HER-2/neu protein immunization circumvents tolerance to rat neu: a vaccine strategy for 'self' tumour antigens
Clinical Trials
1998
Authors:
Disis ML, Shiota FM and Cheever MA
Journal:
Immunology
Volume:
93(2)
Page:
192-9
Original Article
Immunization of metastatic breast cancer patients with CD80-modified breast cancer cells and GM-CSF
Clinical Trials
1998
Authors:
Schoof DD, Smith JW 2nd, Disis ML, Brant-Zawadski P, Wood W, Doran T, Johnson E Ubra WJ
Journal:
Gene Therapy of Cancer
Volume:
451
Page:
511-8
Review Article
HER-2/neu oncogenic protein: issues in vaccine development
Cancer Vaccines
1998
Authors:
Disis ML and Cheever MA
Journal:
Critical Reviews in Immunology
Volume:
18(1-2)
Page:
37-45
Original Article
Identification of Her-2/Neu CTL epitopes using double transgenic mice expressing HLA-A2.1 and human CD.8
Cancer Vaccines
1997
Authors:
Lustgarten J, Theobald M, Labadie C, LaFace D, Peterson P, Disis ML, Cheever MA and Sherman LA
Journal:
Human Immunology
Volume:
52(2)
Page:
109-18
Review Article
HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer
Cancer Vaccines
1997
Authors:
Disis ML and Cheever MA
Journal:
Advances in Cancer Research
Volume:
71
Page:
343-71